Increasing life expectancy in cystic fibrosis: Advances and challenges.
Increasing life expectancy in cystic fibrosis: Advances and challenges.
复制标题
DOI:
10.1002/ppul.25733
复制
发表时间:
2022-03
影响因子:
3.1
通讯作者:
Konstan, Michael W.
中科院分区:
文献类型:
--
作者:
McBennett, Kimberly A.;Davis, Pamela B.;Konstan, Michael W.
Since the first description of cystic fibrosis in 1938, there have been significant advances in both quality of life and longevity for people living with this disease. In this article we describe the milestones of the last 80 years and what we perceive to be the remaining barriers to normalcy for this population.
登录
查看更多内容
影响因子:
10
作者:
Floto RA;Olivier KN;Saiman L;Daley CL;Herrmann JL;Nick JA;Noone PG;Bilton D;Corris P;Gibson RL;Hempstead SE;Koetz K;Sabadosa KA;Sermet-Gaudelus I;Smyth AR;van Ingen J;Wallace RJ;Winthrop KL;Marshall BC;Haworth CS;US Cystic Fibrosis Foundation and European Cystic Fibrosis Society
通讯作者:
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society
影响因子:
5.2
作者:
Flume, Patrick A.;Wainwright, Claire E.;Wagener, Jeffrey S.
通讯作者:
Wagener, Jeffrey S.
影响因子:
120.7
作者:
DAVIS, PB;DISANTAGNESE, PA
通讯作者:
DISANTAGNESE, PA
影响因子:
9.6
作者:
Buu, MyMy C.;Sanders, Lee M.;Wise, Paul H.
通讯作者:
Wise, Paul H.
影响因子:
3.9
作者:
Dagenais RVE;Su VCH;Quon BS
通讯作者:
Quon BS